(Q29547778)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

1 reference

0 references

Oddo S

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

Caccamo A

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

Shepherd JD

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

Murphy MP

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

Golde TE

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

Kayed R

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

Metherate R

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

Mattson MP

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

Akbari Y

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

LaFerla FM

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

language of work or name

1 reference

23 April 2017

publication date

31 July 2003

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

volume

39

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

page(s)

409-21

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

23 April 2017

issue

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12895417

A synaptic model of memory: long-term potentiation in the hippocampus

23 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Overexpression of growth-associated proteins in the neurons of adult transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Correlations of synaptic and pathological markers with cognition of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Tau filament formation in transgenic mice expressing P301L tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Intraneuronal Abeta42 accumulation in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

APP processing and synaptic function

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

A plasticity-based theory of the pathogenesis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Quantitation of synaptic density in the septal nuclei of young and aged Fischer 344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Abeta42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and pick bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Alzheimer's disease is a synaptic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Facilitation, augmentation and potentiation at central synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Genetically engineered mouse models of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021

Short-term synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900434-3

7 January 2021